...
首页> 外文期刊>Japanese journal of clinical oncology. >Risk factors for lymphatic complications following lymphadenectomy in patients with cervical cancer
【24h】

Risk factors for lymphatic complications following lymphadenectomy in patients with cervical cancer

机译:宫颈癌患者淋巴结切除术后淋巴并发症的危险因素

获取原文
获取原文并翻译 | 示例

摘要

Background: The purpose of this study was to evaluate the occurrence of lymphatic complications following pelvic lymphadenectomy (PLA) in patients with cervical cancer. Methods: A retrospective study of 169 cervical cancer patients was conducted. Lower extremity lymphedema (LEL) was diagnosed using the International Society of Lymphology guidelines, and pelvic lymphocele (PL) was evaluated using trans-vaginal ultrasonography and computed tomography. Results: The median patient age was 46 years (range: 22-74) and median body mass index was 21.7 kg/m~2 (range: 15.7-37.1). The median number of lymph nodes (LNs) removed was 27 (range: 22-74); 94 (55.6%) patients underwent circumflex iliac node (CIN) dissection; 39 (23.1%) patients received adjuvant chemotherapy; and 81 (47.9%) patients received adjuvant postoperative radiotherapy. There were 28 (16.6%) and 32 (18.9%) occurrences of LEL and PL, respectively. In multi-variate logistic regression analysis, the number of LNs removed (odds ratio [OR]: 3.37; 95% CI: 1.43-8.54; P = 0.0053) and CIN removal (OR: 3.92; 95% CI: 1.55-11.4; P = 0.0033) were independent risk factors for LEL; however, no risk factors were significantly associated with PL. Conclusions: Our results demonstrated that CIN removal and the number of LNs removed were significant risk factors for LEL in patients with cervical cancer. However, we did not identify any significant risk factors for PL in this study. We instead speculate that LN dissection itself causes PL. We suggest that establishment of comprehensive PLA without CIN dissection, or use of the sentinel lymph node concept, will prevent the occurrence of lymphatic complications in cervical cancer patients.
机译:背景:本研究的目的是评估宫颈癌患者骨盆淋巴结切除术(PLA)后淋巴并发症的发生。方法:进行了对169例宫颈癌患者的回顾性研究。利用国际淋巴管准则学会诊断患者下肢淋巴管(LEL),使用跨阴道超声和计算机断层扫描评估骨盆淋巴细胞(PL)。结果:中位数患者年龄为46岁(范围:22-74),中位体重指数为21.7千克/ m〜2(范围:15.7-37.1)。移除的淋巴结(LNS)中位数为27(范围:22-74); 94(55.6%)患者接受了Circurex iliac节点(CIN)解剖; 39(23.1%)患者接受佐剂化疗; 81(47.9%)患者接受佐剂术后放疗。分别有28个(16.6%)和32个(18.9%)的lek和pl。在多变型物流回归分析中,所删除的LNS数量(差距[或]:3.37; 95%CI:1.43-8.54; p = 0.0053)和CIN去除(或:3.92; 95%CI:1.55-11.4; p = 0.0033)是LEL的独立风险因素;但是,没有危险因素与PL显着相关。结论:我们的结果表明,宫颈癌患者中,消除COM去除和LNS的数量是LEL的显着风险因素。但是,我们在本研究中没有确定PL的任何重大风险因素。我们推测了LN解剖本身导致PL。我们建议在没有Cin解剖的情况下建立综合解放,或者使用Sentinel淋巴结概念,将防止宫颈癌患者淋巴并发症的发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号